Raia Drogasil S.A
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.
Raia Drogasil S.A (RADL3) - Total Liabilities
Latest total liabilities as of December 2025: R$18.14 Billion BRL
Based on the latest financial reports, Raia Drogasil S.A (RADL3) has total liabilities worth R$18.14 Billion BRL as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Raia Drogasil S.A - Total Liabilities Trend (2000–2025)
This chart illustrates how Raia Drogasil S.A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Raia Drogasil S.A Competitors by Total Liabilities
The table below lists competitors of Raia Drogasil S.A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sabra Healthcare REIT Inc
NASDAQ:SBRA
|
USA | $2.67 Billion |
|
Hankyu Hanshin Holdings Inc
F:HKY
|
Germany | €2.17 Trillion |
|
Isetan Mitsukoshi Holdings Ltd
F:4HP
|
Germany | €588.59 Billion |
|
Gotion High tech Co Ltd
SHE:002074
|
China | CN¥86.89 Billion |
|
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
|
USA | $528.12 Million |
|
National Silicon Industry Group Co Ltd
SHG:688126
|
China | CN¥13.71 Billion |
|
AAK AB (publ.)
OTCGREY:ARHUF
|
USA | $12.65 Billion |
|
VERBUND AG
PINK:OEZVF
|
USA | $6.46 Billion |
Liability Composition Analysis (2000–2025)
This chart breaks down Raia Drogasil S.A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.46 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Raia Drogasil S.A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Raia Drogasil S.A (2000–2025)
The table below shows the annual total liabilities of Raia Drogasil S.A from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | R$18.14 Billion | +15.53% |
| 2024-12-31 | R$15.70 Billion | +11.61% |
| 2023-12-31 | R$14.07 Billion | +19.38% |
| 2022-12-31 | R$11.78 Billion | +17.16% |
| 2021-12-31 | R$10.06 Billion | +6.96% |
| 2020-12-31 | R$9.40 Billion | +15.06% |
| 2019-12-31 | R$8.17 Billion | +114.08% |
| 2018-12-31 | R$3.82 Billion | +18.77% |
| 2017-12-31 | R$3.21 Billion | +18.01% |
| 2016-12-31 | R$2.72 Billion | +33.34% |
| 2015-12-31 | R$2.04 Billion | +28.26% |
| 2014-12-31 | R$1.59 Billion | +23.72% |
| 2013-12-31 | R$1.29 Billion | +19.67% |
| 2012-12-31 | R$1.08 Billion | +11.21% |
| 2011-12-31 | R$967.13 Million | +198.80% |
| 2010-12-31 | R$323.67 Million | +1.35% |
| 2009-12-31 | R$319.35 Million | +32.58% |
| 2008-12-31 | R$240.87 Million | +21.07% |
| 2007-12-31 | R$198.94 Million | +12.01% |
| 2006-12-31 | R$177.62 Million | +12.27% |
| 2005-12-31 | R$158.21 Million | +69.45% |
| 2004-12-31 | R$93.37 Million | +34.56% |
| 2003-12-31 | R$69.39 Million | +13.56% |
| 2002-12-31 | R$61.10 Million | +21.05% |
| 2001-12-31 | R$50.48 Million | +2.27% |
| 2000-12-31 | R$49.36 Million | -- |